Chronic cyclosporine (CsA)-induced nephrotoxicity is factor expression in normal and cyclosporine-treated rat kidney.
understood, but has been attributed to sustained afferent pression in an experimental model of chronic cyclosporine arteriolar vasoconstriction and arteriopathy [2, 3] .
(CsA) nephrotoxicity in rats.
The lack of an animal model of chronic CsA nephroMethods. Two separate experiments were performed. In the toxicity has hampered the study of the mechanisms of first experiment, rats on the normal-salt diet (NSD; 0.3%) or low-salt diet (LSD; 0.05%) were treated with or without LSRT renal damage. However, a reproducible animal model for four weeks. In the second experiment, rats on the NSD or of chronic CsA nephrotoxicity was established from the LSD were given vehicle (VH group, olive oil, 1 mg/kg per day) observation that sodium depletion exacerbates CsA or CsA (15 mg/kg per day) or CsA (15 mg/kg per day) plus LSRT nephrotoxicity [4, 5] . In this model, CsA treatment in (100 mg/L per day). Renal function, histopathology, TUNEL staining, plasma renin activity (PRA), and the expression of rats on a low-salt diet (LSD) induced a histologic feature renin and EGF were studied. similar to that described in patients on long-term CsA
Results. Normal rats on the LSD showed significantly intherapy [6] . Salt depletion activates the renin-angiotencreased EGF expression (cortex, 2.6-fold; medulla, 1.7-fold) sin system (RAS), which has been implicated in the and significantly decreased EGF expression with the LSRT changes in renal hemodynamics and function that follow treatment compared with the rats treated with the NSD (cortex, 74.8 vs. 10%; medulla, 22.5 vs. 5%). In contrast, the CsACsA administration [7] . Furthermore, angiotensin-contreated rats on the LSD had a significantly lower EGF expresverting enzyme inhibitor or angiotensin II (Ang II) resion (cortex, 98 vs. 53%; medulla, 94 vs. 14%); however, conceptor antagonist is effective in preventing interstitial comitant administration of LSRT increased the EGF expresfibrosis [8] by inhibiting the expression of intrarenal sion (cortex, 91-vs. 3.8-fold; medulla, 19-vs. 2.4-fold) compared with the rats on the NSD. In the normal and CsA-treated transforming growth factor-␤1 (TGF-␤1) [9] .
LSD rats, EGF expression was well correlated with PRA. In Epidermal growth factor (EGF) is a 53-amino acid addition, EGF expression was well correlated with the intersti-(6.2 kD) polypeptide that stimulates the proliferation tial fibrosis score (r ϭ 0.664, P Ͻ 0.01) or number of TUNELand differentiation of epithelial cells as well as being positive cells (r ϭ 0.822, P Ͻ 0.01) in CsA-treated LSD rats.
Conclusions. These results suggest that angiotensin II blockmitogenic for various other cell types in culture [10, 11] .
ade with LSRT decreases EGF expression in normal rats on
In addition, EGF is thought to be important in the mainthe LSD, but it protects EGF expression in CsA-induced nephtenance of renal tubule integrity and in the tubular regenrotoxicity. This finding provides a new perspective on the renoerative response to injury [12, 13] . Animal studies show protection of angiotensin II blockade in chronic CsA nephrotoxicity.
that EGF accelerates renal tubular regeneration in rat models of acute renal failure [14] , whereas treatment with anti-EGF antibody inhibits tubular cell prolifera-gensen et al reported that urinary excretion of EGF in living human kidney recipients is 40% lower than in donor (1) NSD rats received a 0.4% sodium content diet for four weeks (N ϭ 6). (2) NSD-LSRT rats compensatory renal growth, suggesting decreased urinary EGF excretion by ischemic or CsA-induced toxicity [16] . received a 0.4% sodium content diet plus LSRT (100 mg/L) in the drinking water for 28 days (N ϭ 6). Di Paolo et al reported that the renal expression and the urinary concentration of the EGF signal are ex-(3) LSD rats received a 0.05% sodium content diet for four weeks (N ϭ 6). (4) LSD-LSRT rats received a 0.05% tremely weak or even absent in patients with acute rejection, acute tubular necrosis, and CsA nephrotoxicity [17] .
sodium content diet and LSRT (100 mg/L) in the drinking water for 28 days (N ϭ 6). Stein-Oakley et al reported that chronic renal allograft rejection shows decreased expression of EGF in a rat Protocol 2. This study was designed to evaluate the role of RAS in regulating EGF expression in CsA-treated model [18] . These findings suggest that tubular damage by ischemia, nephrotoxic drugs, or rejection decreases rat kidney and to examine the effect of blocking the AT1 receptor on EGF expression. The NSD or an LSD was EGF expression.
The association of EGF expression and RAS is well administered to the each group. (1) The vehicle (VH) group of rats received a daily subcutaneous injection of known from studies in vitro and in the developing kidney [19] . Angiotensin II potentiates the mitogenic action of olive oil, 1 mg/kg for four weeks (N ϭ 6). (2) CsA rats received a daily subcutaneous injection of CsA (15 mg/kg) EGF on proximal tubular cells [20] , and the inhibition of angiotensin II type 1 (AT1) receptors decreases the for four weeks (N ϭ 6). (3) CsA ϩ LSRT rats received a daily subcutaneous injection of CsA (15 mg/kg) and LSRT renal expression of EGF in neonatal rats [21] . Based on these observations, we hypothesized that EGF expression (100 mg/L) was added to the drinking water for four weeks (N ϭ 6). may be influenced by RAS in chronic CsA nephrotoxicity. To test this hypothesis, two separate experiments This dosage and route of administration for LSRT were selected because they have been previously shown were performed. First, we evaluated the difference in EGF expression of normal rats on a low-salt diet (LSD) to blockade Ang II receptors significantly [22] . or a normal-salt diet (NSD), and evaluated the influence Basic protocol of Ang II blockade on EGF expression. Second, EGF expression was evaluated in CsA-treated rats with an After one week of the animals on the NSD or LSD, weight-matched rats were randomly assigned to the dif-LSD or an NSD, and the influence of Ang II blockade on EGF expression was evaluated in normal and CsAferent treatment groups. Daily body weights were recorded. After each treatment period, the systolic blood treated rat kidneys. Our study clearly demonstrates the influences of RAS on intrarenal EGF expression in rats pressure was measured with a plethysmography using a tail manometer-tachometer system (BP-2000; Visitech with or without CsA treatment.
Systems, Apex, NC, USA), and 24-hour urine samples were collected in metabolic cages (Nalge Co., Rochester, METHODS NY, USA). The following day, animals were anestheAnimals tized with ketamine, and a blood sample and tissue specimens were obtained. Male Sprague-Dawley rats (Charles River, Wilmington, MA, USA), weighing 225 to 250 g, were housed in Functional studies individual cases in a temperature-and light-controlled environment. They received the LSD (0.05% sodium;
Urinary and serum creatinine was measured by a Cobas autoanalyzer (Roche Diagnostics, Div. Hoffman-La Teklad Premier, Madison, WI, USA) or NSD (0.4% sodium; Teklad Premier). NSD rats were pair fed with Roche Inc., Nutley, NJ, USA). The creatinine clearance (C Cr ) was calculated using a standard formula. The whole-LSD animals.
blood CsA concentrations were measured by monoclonal Drugs radioimmunoassay (Incstar Co., Stillwater, MN, USA). Plasma renin activity (PRA) was measured by radioCyclosporine provided by Sandoz Research (East Hanover, NJ, USA) was diluted in olive oil to a final conimmunoassay (Angiotensin I-Biotecx radioimmunoassay; Biotecx, Friendswood, TX, USA). centration of 15 mg/mL. Losartan (LSRT), provided by Cardiovascular Diseases Research, DuPont-Merck PharHistology maceutical (Wilmington, DE, USA) was dissolved in sterile water to a final concentration of 100 mg/L.
These histologic findings were evaluated as previously described [23] . Tubulointerstitial fibrosis (TIF) was estiExperimental groups mated semiquantitatively using a color image analyzer (Mustek Paragon 800 SP, Macintosh PowerPC 7100, NIH Two separate experiments were conducted. The first experiment (protocol 1) was designed to evaluate the role of Image version 1.5) by counting the percentage of injured areas per field of cortex and medulla. Scores of 0 to 3ϩ RAS in regulating EGF expression in normal rat kidney. strength Tdt enzyme solution in a humidified chamber at 37ЊC for two hours. The reaction was terminated by incubation in working-strength stop/wash buffer for 30 minutes at 37ЊC. After being rinsed with phosphate-buffered saline (PBS), the sections were incubated with anti-digoxi-1:10,000; Bio-Rad] for 30 minutes. Antibody-reactive genin peroxidase in a humidified chamber for 30 minutes protein was detected using enhanced chemiluminescence at room temperature. Sections were then incubated with (Amersham Life Science, Little Chalfont, Buckinghamdiaminobenzidine and 0.01% H 2 O 2 for five minutes at shire, UK). Densitometric analysis was performed using room temperature. After being rinsed with PBS, the secGelexpert software (Nucleotech Corp., San Carlos, CA, tions were counterstained with hematoxylin and exam-USA). Optical densities (mean Ϯ SEM) were obtained ined by light microscopy. To quantitate TUNEL-positive after three determinations for each band. cells, 16 fields of outer medulla were randomly selected in each section and observed under a microscope (magniImmunohistochemistry of EGF and renin fication ϫ400). The number of apoptotic cells was exSections were dewaxed. Before incubation with pripressed per 1000 of the total tubular cells in each section. mary antibody, the sections were blocked with normal rabbit serum diluted 1:10 in 0.3% bovine serum albumin Immunoblotting for EGF (BSA) for 30 minutes and incubated for two hours at Kidneys were homogenized in RIPA [10 mmol/L Tris 4ЊC in mouse antiserum against EGF (Biomedical TechCl, pH 7.6, 150 mmol/L NaCl, 1% (wt/vol) sodium deoxynologies Inc., Stoughton, MA, USA) diluted 1:200 in BSA. cholate, 1% (vol/vol) Triton X-100, 0.1% (wt/vol) soThe sections were rinsed in TBS and incubated for 30 dium dodecyl sulfate, 1% (vol/vol) aprotinin, 2 mmol/L minutes in peroxidase-conjugated rabbit anti-mouse IgG Na 3 VO 4 , and freshly added leupeptin (1 g/mL), pep-(Jackson ImmunoResearch Laboratories Inc., West Grove, statin (1 g/mL), and 1 mmol/L phenylmethylsulfonyl PA, USA). Sections were incubated with a mixture of fluoride (PMSF)]. Homogenates were centrifuged at 0.05% 3,3Ј-diaminobenzidine and 0.01% H 2 O 2 for five 16,000 ϫ g for 15 minutes at 4ЊC, and protein concentraminutes at room temperature, washed with Tris-HCl buftions were determined using a protein microassay of fer, counterstained with hematoxylin, and examined by Bradford method (Bio-Rad, Hercules, CA, USA). Holight microscopy. The method for renin immunohistomogenates were heated at 94ЊC for five minutes. Proteins chemistry was same as EGF immunohistochemistry. The were separated by sodium dodecyl sulfate-polyacrylnumber of renin-positive glomeruli was counted per 50 amide gel electrophoresis (SDS-PAGE) in 15% polyglomeruli. acrylamide gels and were electroblotted onto Bio-Blot nitrocellulose (Costar, Cambridge, MA, USA). NonspeStatistical analysis cific binding was blocked by incubating the blots for Data reported are mean Ϯ SEM, and all statistical one hour in 5% (wt/vol) nonfat milk. Epidermal growth analyses were calculated with SYSTAT for Macintosh factor was detected by incubating for one hour with a version 5.2 (SYSTAT Inc., Chicago, IL, USA). Comparipolyclonal anti-EGF antibody (Santa Cruz Biotechnolsons between groups were done by analysis of variance ogy, Inc., Santa Cruz, CA, USA) diluted 1:1000. Primary (Kruskal-Wallis test followed by Tukey or Dunnet test) antibody incubation was followed by six washes of Trisor unpaired t test. Nonparametric (Spearman) correlabuffered saline with 0.005% Tween 20 (TBS-T). The blot tion coefficient was calculated. The level of statistical was then incubated with secondary antibody [goat-antirabbit IgG-horseradish peroxidase (HRP) conjugate at significance was P Ͻ 0.05. Table 1 shows the blood pressure and renal function in the experimental groups. At four weeks, systolic blood pressure was increased in the CsA group with an NSD, but there was no significant change in the CsA group with an LSD. The addition of LSRT decreased systolic blood pressure compared with the VH group on the NSD and LSD. The CsA group with an NSD and an LSD showed a significant decrease in C Cr and a significant increase in serum creatinine compared with the VH group (P Ͻ 0.05, respectively). However, there were no significant differences in C Cr between CsA and CsA ϩ LSRT groups with NSD or LSD. concurrent administration of LSRT dramatically decreased TIF (Fig. 1C) . When the extent of changes in TIF was graded with a 0 to 3ϩ semiquantitative score, there were no differences in the TIF scores among VH (0.17 Ϯ 0.14), with LSRT treatment. Figure 4 shows the comparison CsA (0.21 Ϯ 0.19), and CsA ϩ LSRT groups (0.19 Ϯ of TUNEL-positive cells in the CsA-treated rats on the 0.18) on a NSD. However, in the LSD group, there was NSD and LSD. In the NSD group, there was no signifia significant increase in TIF score in the CsA group cant increase in the number of TUNEL-positive cells compared with the VH group (2.07 Ϯ 0.56 vs. 0.19 Ϯ with CsA treatment compared with the VH group (4.8 Ϯ 0.13, P Ͻ 0.05). The concomitant administration of LSRT 2.5 vs. 2.2 Ϯ 1.6, P Ͼ 0.05), and LSRT treatment did decreased the TIF score in comparison with the CsA not affect apoptotic cell death (3.9 Ϯ 1.7). In the LSD group (1.25 Ϯ 0.25; Fig. 2) .
RESULTS

Blood pressure and functional assessment
Histologic assessment
group, CsA treatment increased the number of TUNELApoptoic cell death in CsA-treated rats positive cells compared with the VH group (52.1 Ϯ 15.5 vs. 2.3 Ϯ 0.9, P Ͻ 0.05), and concomitant administration Figure 3 shows TUNEL-staining in chronic CsA nephof LSRT significantly decreased the number of TUNELrotoxic rats on the LSD. In the VH group, TUNEL-posipositive cells (15.6 Ϯ 3.0) as compared with the CsA tive cells were rarely observed. The number of TUNELpositive cells increased with CsA treatment, but decreased group (P Ͻ 0.05). 
CsA-treated rats
Immunohistochemistry of renin in VH and CsA groups. In the VH group, there was minimal immunoreactivity of renin, but its immunoreactivity nin-positive glomeruli were increased in the kidneys with CsA treatment. Quantitative analysis showed a significant increase in the number of renin-positive glomeruli in rats on the LSD compared with the NSD in the VH 5.6 vs. 3.1 Ϯ 1.7, P Ͻ 0.05). CsA treatment increased group (11 Ϯ 3 vs. 6 Ϯ 2, P Ͻ 0.05). CsA treatment PRA in both the NSD (9.3 Ϯ 2.8) and the LSD (38.8 Ϯ increased renin-positive glomeruli compared with the 6.2) compared with the VH group (P Ͻ 0.05, respec-VH group in both the NSD and LSD, but a greater intively). The concomitant administration of LSRT sigcrease was observed in the LSD group (25 Ϯ 2 vs. 15 Ϯ nificantly increased PRA (26.3 Ϯ 5.0) in the NSD, but 3, P Ͻ 0.05).
there was a dramatic decrease of RPA in the LSD (7.0 Ϯ In the VH group, PRA was significantly increased in 1.8) as compared with the CsA (P Ͻ 0.05, respectively; Fig. 6 ). the LSD group compared with the NSD group (13.8 Ϯ bules and in the thick ascending limb of Henle (Fig. 9A, B) .
Influence of the renin-angiotensin system on EGF
In the CsA group, immunoreactivity of EGF protein was expression in normal rats almost undetectable in both renal tubular cells ( LSRT dramatically increased immunoreactivity of EGF expression was significantly increased (cortex, 40 Ϯ 3 vs.
in both tubules (Fig. 9E, F ). 103 Ϯ 8; medulla, 77 Ϯ 15 vs. 151 Ϯ 19, P Ͻ 0.05, Relationship between plasma renin activity and respectively) compared with the rat kidney with the NSD EGF expression (Fig. 7) . A concomitant administration of LSRT did not affect EGF expression in the NSD, but there was a sig-
The association between RAS with EGF expression nificant decrease of EGF expression in rats with the LSD was evaluated in normal and CsA-treated rats (Fig. 10 ). (cortex, 103 Ϯ 8 vs. 26 Ϯ 5; medulla, 151 Ϯ 19 vs. 117 Ϯ With the LSD, EGF expression was positively correlated 16, P Ͻ 0.05, respectively).
with PRA in normal rats (cortex, r ϭ 0.847; medulla, r ϭ 0.899), but was negatively correlated with PRA in Influence of the renin-angiotensin system on EGF CsA-treated rats (cortex, r ϭ 0.747; medulla, r ϭ 0.722). expression in CsA-treated rats Association between EGF expression and The immunoblot and optical density of EGF are interstitial fibrosis or apoptotic cell death shown in Figure 8 . Immunoblotting for EGF protein in chronic CsA nephrotoxicity provided a single band at 6 kD. In the NSD group, CsA treatment for four weeks significantly decreased EGF
The association between EGF expression and apoptotic expression (cortex, 81 Ϯ 8 vs. 38 Ϯ 3; medulla, 85 Ϯ 9 cell death or interstitial fibrosis in chronic CsA nephrovs. 73 Ϯ 6, P Ͻ 0.05, respectively), and CsA treatment toxicity was evaluated (Fig. 11) . Epidermal growth factor in the LSD group almost completely inhibited EGF exexpression was well correlated with TIF (r ϭ 0.664, P Ͻ pression (cortex, 94 Ϯ 10 vs. 2.0 Ϯ 0.5; medulla, 219 Ϯ 0.01) and the number of TUNEL-positive cells (r ϭ 24 vs. 14 Ϯ 2.5, P Ͻ 0.05, respectively). With a concurrent 0.822, P Ͻ 0.01). administration of LSRT, EGF expression was significantly increased in the NSD (vs. 182 Ϯ 17, P Ͻ 0.05) DISCUSSION and the LSD (vs. 269 Ϯ 19, P Ͻ 0.05).
The results of our study clearly demonstrate EGF exImmunohistochemistry of EGF pression in normal and CsA-treated rat kidneys according to the status of RAS. In normal rats, EGF expression Immunostaining of EGF in the VH group showed welllocalized immunoreactivity in the distal convoluted tuwas significantly higher in rats on the LSD compared with the NSD rats, and inhibition of EGF expression pared with the NSD rats. This finding confirms that activation of RAS with an LSD is essential to induce the by LSRT was observed only in rats on the LSD. On the other hand, CsA-treated rats showed a decreased EGF pathologic lesion of chronic CsA nephrotoxicity and that LSD augments activation of RAS by CsA. expression, but Ang II blockade with LSRT preserved the EGF expression, with the effect being more definite Our study clearly demonstrates that EGF expression in the kidney is regulated by the activity of RAS in normal in the LSD rats. This finding suggests that EGF expression is influenced by the status of RAS in rat kidney.
rats. To define the role of RAS in regulating EGF expression, diets of different sodium contents (NSD vs. LSD) The RAS plays an important role in the pathogenesis of the experimental model of chronic CsA nephrotoxicwere used. The rats on an LSD showed a significantly increased EGF expression compared with the rats on an ity [7] . CsA administration in salt-depleted rats causes a significant increase in juxtaglomerular apparatus renin, NSD (cortex, 2.6-fold; medulla, 1.7-fold). In addition, LSRT treatment significantly decreased the EGF expresand CsA-induced interstitial fibrosis could be prevented by the use of LSRT or enalapril [8] . Others have demonsion in LSD rats, but there was no significant decrease in EGF expression in NSD rats (cortex, 74.8 vs. 10%; strated a beneficial effect with Ang II blockade on CsAinduced afferent arteriolopathy and a decrease in the macmedulla, 22.5 vs. 5%). Moreover, EGF expression was well correlated with PRA (cortex, r ϭ 0.847; medulla, r ϭ rophage chemoattractant osteopontin [23] . In the present study, typical chronic CsA nephrotoxicity was observed 0.899). Based on these observations, we propose that EGF expression in the normal rat kidney is dependent only in the LSD rats. In addition, CsA with LSD further increased PRA and intrarenal expression of renin comon the activity of RAS. In contrast to rats not receiving CsA treatment, EGF is conceivable that CsA has a direct toxic effect on EGF expression; the LSD, which enhances the hemodynamic expression decreased in CsA-treated rats on both diets, but a more significant decrease was observed in rats with effect of Ang II, might potentiate this effect. One interesting finding in this study is the overexpresthe LSD compared with the NSD (cortex, 98 vs. 53%; medulla, 94 vs. 14%). The same result was also observed sion of EGF with the Ang II blockade in CsA-treated NSD rats (cortex, 1.9-fold; medulla, 2.0-fold) or with the when LSRT and CsA were coadministered. The Ang II blockade significantly increased EGF expression in LSD LSD (cortex, 2.0-fold; medulla, 1.2-fold) compared with the VH group. This finding suggests that the mechanism and NSD rats, but a more significant decrease was observed in rats on the LSD compared with the NSD (corof preservation of EGF expression by LSRT is more than that of a reduced CsA-induced nephrotoxicity, and that tex, 91-vs. 3.8-fold; medulla, 19-vs. 2.4-fold). In addition, EGF expression was negatively correlated with PRA in RAS may be involved in the process of EGF synthesis in CsA-treated rats. In general, EGF is synthesized as a rats on the LSD (cortex, r ϭ 0.749; medulla, r ϭ 0.722). This finding suggests that enhanced CsA-induced nephtransmembrane prepro-EGF molecule [24, 25] , which is a membrane-attached protein with a membrane-spanrotoxicity by LSD overcomes the action of Ang II, which increases EGF expression in normal rats. In addition, it ning hydrophobic domain adjacent to the EGF moiety [26]. The EGF precursor is not processed to the small Henle and distal convoluted tubules. With CsA treatment, the intensity of EGF immunoreactivity was almost peptide in the kidney [27] nor is it easily solubilized from the cell membrane during the extraction process [28] . undetectable in both tubules. In the CsA ϩ LSRT group, the immunoreactivity of EGF was markedly increased Based on the previously mentioned findings, we can speculate on some possible mechanisms to explain the overin both tubules, which showed more increased immunoreactivity of EGF when compared with the VH group. expression of EGF by LSRT in the CsA-treated rat kidney. First, the Ang II blockade may increase the cleavage This immunohistochemical finding is consistent with the immunoblot result and clearly shows the inhibitory effect of a preformed precursor in CsA-treated rats. Second, the Ang II blockade may inhibit the secretion of a mature of CsA and the protective effect of LSRT treatment on EGF expression in chronic CsA nephrotoxicity. form of EGF in CsA-treated rats. Third, there might be a feedback mechanism between RAS and EGF expresThe molecular mechanism of EGF as a growth factor was studied extensively in an experimental model of sion in the CsA-treated rat kidney. An in vitro study is needed to define the relationship between EGF expresischemia/reperfusion injury, and data exist in favor of an involvement of EGF in regenerative hyperplasia after sion and RAS.
Previous studies have demonstrated that EGF is exrenal injury. Exogenously added EGF has been demonstrated to enhance renal tubule cell regeneration as well pressed in the thick ascending limb of Henle and distal convoluted tubules [29] [30] [31] , which are vulnerable to CsA.
as to lessen the severity and duration of acute renal failure after hypoxic injury [32, 33] or exposure to various In our current study, the VH group showed moderate immunostaining for EGF in the thick ascending limb of nephrotoxins such as mercuric chloride [34] , folic acid fibrosis in CsA-induced nephropathy. Moreover, the protective effect on EGF expression by LSRT might be associated with improvements in both parameters. As expected, EGF expression was well correlated with interstitial fibrosis (r ϭ 0.664) and TUNEL-positive cells (r ϭ 0.822). This finding suggests that the loss of endogenous EGF during chronic CsA nephrotoxicity is associated with increased apoptotic cell death resulting in interstitial fibrosis. On the other hand, experimental approaches aiming to block EGF receptor signaling seem to ameliorate the evolution of renal diseases. Terzi et al reported a reduction of TIF after renal injury in mice with targeted tubular expression of a dominant negative EGF receptor [39] . This finding suggests that inhibition of EGF signaling in the kidney may prevent the development of renal lesions after renal injury. At present, the fate of EGF receptor in renal tissues exposed to CsA or LSRT is unknown because our experimental investigations focused on EGF itself. However, we suggest that intrarenal EGF may be associated with healing processes, but that it may be helpful or harmful according to the clinical situation. When the kidney is damaged by ischemic or toxic injury, EGF may act as a growth factor in the regeneration of renal tubular cells. In contrast, EGF may have a harmful action in the progression of renal disease in an animal model of uremia (5/6 nephrectomy model).
Our study clearly demonstrates that EGF expression is influenced by the status of RAS in normal and CsAtreated rats. EGF expression is decreased by CsA, but is protected by the Ang II blockade with LSRT. This finding provides a new perspective to the renoprotection of Ang II blockade in cases of chronic CsA nephrotoxicity.
